Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids
The synthesis of novel acefyllines and exploring their biological activities attract researchers due to their medicinal applications. Therefore, the current work reports the successful synthesis of a series of novel acefyllines in good yields, and their structures wereconfirmed using various spectro...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2022/3502872 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565811633455104 |
|---|---|
| author | Irum Shahzadi Ameer Fawad Zahoor Bushra Parveen Azhar Rasul Zohaib Raza Sajjad Ahmad Ali Irfan Gamal A. El-Hiti |
| author_facet | Irum Shahzadi Ameer Fawad Zahoor Bushra Parveen Azhar Rasul Zohaib Raza Sajjad Ahmad Ali Irfan Gamal A. El-Hiti |
| author_sort | Irum Shahzadi |
| collection | DOAJ |
| description | The synthesis of novel acefyllines and exploring their biological activities attract researchers due to their medicinal applications. Therefore, the current work reports the successful synthesis of a series of novel acefyllines in good yields, and their structures wereconfirmed using various spectroscopic methods. The synthesized acefyllines demonstrated moderate activity (cell viability = 22.55 ± 0.95% − 57.63 ± 3.65%) compared with the starting drug acefylline (cell viability = 80 ± 3.87%) against the human liver carcinoma (Hep G2 cell line). N-(4-Chlorophenyl)-2-(4-(3,4-dichlorophenyl)-5-((1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetamide exhibited the most potent activity (cell viability = 22.55 ± 0.95%) among the synthesized derivatives. The in silico modeling studies were performed to predict the binding of the most potent derivative with a binding site that agreed with the results of the antiproliferative activity. The newly synthesized heterocycles exhibited the least hemolytic and moderate clot lysis activity. |
| format | Article |
| id | doaj-art-b6864fcf9ed641859ab4a94e2fa80003 |
| institution | Kabale University |
| issn | 2090-9071 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Chemistry |
| spelling | doaj-art-b6864fcf9ed641859ab4a94e2fa800032025-02-03T01:06:38ZengWileyJournal of Chemistry2090-90712022-01-01202210.1155/2022/3502872Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole HybridsIrum Shahzadi0Ameer Fawad Zahoor1Bushra Parveen2Azhar Rasul3Zohaib Raza4Sajjad Ahmad5Ali Irfan6Gamal A. El-Hiti7Department of ChemistryDepartment of ChemistryDepartment of ChemistryDepartment of ZoologyDepartment of PharmacologyDepartment of ChemistryDepartment of ChemistryCornea Research ChairThe synthesis of novel acefyllines and exploring their biological activities attract researchers due to their medicinal applications. Therefore, the current work reports the successful synthesis of a series of novel acefyllines in good yields, and their structures wereconfirmed using various spectroscopic methods. The synthesized acefyllines demonstrated moderate activity (cell viability = 22.55 ± 0.95% − 57.63 ± 3.65%) compared with the starting drug acefylline (cell viability = 80 ± 3.87%) against the human liver carcinoma (Hep G2 cell line). N-(4-Chlorophenyl)-2-(4-(3,4-dichlorophenyl)-5-((1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetamide exhibited the most potent activity (cell viability = 22.55 ± 0.95%) among the synthesized derivatives. The in silico modeling studies were performed to predict the binding of the most potent derivative with a binding site that agreed with the results of the antiproliferative activity. The newly synthesized heterocycles exhibited the least hemolytic and moderate clot lysis activity.http://dx.doi.org/10.1155/2022/3502872 |
| spellingShingle | Irum Shahzadi Ameer Fawad Zahoor Bushra Parveen Azhar Rasul Zohaib Raza Sajjad Ahmad Ali Irfan Gamal A. El-Hiti Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids Journal of Chemistry |
| title | Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids |
| title_full | Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids |
| title_fullStr | Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids |
| title_full_unstemmed | Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids |
| title_short | Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids |
| title_sort | acefylline derivatives as a new class of anticancer agents synthesis molecular docking and anticancer hemolytic and thrombolytic activities of acefylline triazole hybrids |
| url | http://dx.doi.org/10.1155/2022/3502872 |
| work_keys_str_mv | AT irumshahzadi acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids AT ameerfawadzahoor acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids AT bushraparveen acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids AT azharrasul acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids AT zohaibraza acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids AT sajjadahmad acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids AT aliirfan acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids AT gamalaelhiti acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids |